Integragen
Research Integragen (ALINT) on Bullrun: market cap EUR 1.18M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALINT
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 1.18M
- Financial periodFY2023
- RevenueEUR 12.54M
- Revenue growth-4.8%
- Net income-EUR 171.40K
- Gross margin40.0%
Valuation Snapshot
latest market cap is EUR 1.18M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2023 | EUR 12.54M | -EUR 171.40K | n/a | 40.0% | n/a | EUR 1.83M | EUR 1.12M | EUR 2.01M |
| FY2022 | EUR 13.17M | -EUR 3.51K | n/a | 36.0% | 0 | EUR 2.46M | EUR 1.67M | EUR 2.18M |
| FY2021 | EUR 11.32M | EUR 15.41K | n/a | 36.6% | 0 | EUR 2.94M | EUR 1.95M | EUR 2.19M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 1.18M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Integragen
IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company's genomic pharma services DNA sequencing for oncology and rare disease research; and NGS testing for cancer research.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Integragen's market cap?
Integragen's market capitalization is EUR 1.18M.
What does Integragen do?
IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company's genomic pharma services DNA sequencing for oncology and rare disease research; and NGS testing for cancer research.